Marinus Pharmaceuticals, Inc. Public Market Comparables
Find the most relevant public market comparables for Marinus Pharmaceuticals, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapeutics to treat seizure disorders. Its product, ZTALMY® (ganaxolone) oral suspension CV, is an FDA-approved prescription medication for CDKL5 deficiency disorder.
Business Model
Development and commercialization of pharmaceutical products, specifically therapeutics for seizure disorders.
Target Customers
Physicians and patients with seizure disorders, particularly CDKL5 deficiency disorder. The company also has a global access program to expand reach to patients in areas without commercial availability.
Specific Focus
Treatment of rare and difficult-to-treat seizure disorders, particularly CDKL5 deficiency disorder.
Location
Radnor, Pennsylvania
CEO
Scott Braunstein
Industry
Life sciences
Sub Sector
Neurology/Rare Disease
3yr Revenue Growth
1,704%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Marinus Pharmaceuticals, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Marinus Pharmaceuticals, Inc.? Our platform provides detailed analysis of Marinus Pharmaceuticals, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Marinus Pharmaceuticals, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Marinus Pharmaceuticals, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals sector, Marinus Pharmaceuticals, Inc. operates in the specialized Neurology/Rare Disease sub-sector. Understanding how Marinus Pharmaceuticals, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Neurology/Rare Disease space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Dynavax Technologies Corp
Healthcare • Life sciences
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing vaccines to help protect against infectious diseases. The company leverages its proprietary vaccine adjuvant technology to address various medical needs. Its major product is Heplisav-B, a hepatitis B vaccine approved for use in adults. The company also has CpG 1018 adjuvant used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines, and is advancing a pipeline of vaccine candidates, including those for shingles and plague.
Sayari Labs Inc.
Technology • Software & services
Sayari Labs Inc. is a provider of risk intelligence solutions that empower governments, multinational corporations, and financial institutions to analyze and understand complex global networks of commercial and financial relationships. They specialize in counterparty and supply chain risk intelligence, using data from over 250 jurisdictions to uncover hidden risks, enhance transparency, and promote safer global commerce. Their flagship product, Sayari Graph, is a network analysis platform providing visibility into connections between corporate entities.
G-P
Software & Services • Software & services
G-P is the recognized leader in global employment, providing solutions for companies of all sizes to build and manage global teams in 180+ countries. They offer SaaS-based Employer of Record (EOR), Contractor, and Advisor products, supported by a large team of in-country HR, legal, and compliance experts and proprietary generative AI.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Marinus Pharmaceuticals, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free